Evotec SE Profile Avatar - Palmy Investing

Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibr…
Drug Manufacturers - Specialty & Generic
DE, Hamburg [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million EUR. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
-21.00 - - 10.00 11.00 6.00 -3.00 15.00 67.00 10.00 156.00 42.00 44.00 122.00 203.00 33.00
Operating Cash (Net)
-21.00 - - 10.00 11.00 6.00 -3.00 15.00 67.00 10.00 156.00 42.00 44.00 122.00 203.00 33.00
Accounts Receivable
-2.00 -6.00 - - -4.00 -2.00 -9.00 4.00 -4.00 -7.00 -1.00 -32.00 -4.00 -48.00 -38.00 - -
Accounts Payable
-2.00 1.00 - - -3.00 - - 2.00 -8.00 -1.00 1.00 5.00 -2.00 2.00 31.00 24.00 - -
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-2.00 -9.00 -15.00 5.00 -31.00 2.00 -23.00 -5.00 -269.00 -39.00 -86.00 -155.00 -243.00 -415.00 -23.00
Capital Expenditure
-2.00 -2.00 -8.00 -10.00 -5.00 -5.00 -11.00 -10.00 -17.00 -27.00 -31.00 -99.00 -118.00 -181.00 -215.00
Purchases of Investments
-24.00 -74.00 -89.00 -62.00 -45.00 -26.00 -108.00 -17.00 -78.00 -24.00 -25.00 -70.00 -123.00 -355.00 -72.00
Sale/Maturity of Investment
24.00 65.00 82.00 81.00 19.00 37.00 59.00 65.00 96.00 8.00 22.00 54.00 27.00 205.00 261.00
Property, Plant, Equipment (P&PE)
-2.00 -2.00 -8.00 -10.00 -5.00 -5.00 -11.00 -10.00 -17.00 -27.00 -31.00 -99.00 -118.00 -181.00 -215.00
Acquisitions (Net)
- - 1.00 - - -3.00 -1.00 -2.00 37.00 -43.00 -270.00 5.00 -52.00 -33.00 -21.00 -79.00 2.00
Other Investing Activities
- - - - - - - - - - 1.00 -49.00 44.00 - - -2.00 - - -6.00 -7.00 -4.00 197.00
Financing Activities
Used Cash (Net)
-1.00 -3.00 -2.00 -2.00 -31.00 -3.00 -2.00 -19.00 -240.00 -77.00 -211.00 -246.00 -398.00 -52.00 -84.00
Debt Repayment
-3.00 -4.00 -12.00 - - - - -4.00 - - -42.00 -30.00 -79.00 -70.00 -26.00 -36.00 -53.00 -107.00
Dividends Paid
-4.00 - - - - - - - - -1.00 - - - - - - - - - - - - - - - - - -
Common Stock
- - - - 2 - - 30 - - - - - - - - - - - - - - - - - - - -
Other Financing Activities
8.00 - - 15.00 2.00 32.00 -1.00 - - 22.00 181.00 1.00 279.00 23.00 31.00 - - -12.00
Cash Balances
Begin of Period
55.00 32.00 21.00 17.00 39.00 45.00 48.00 44.00 83.00 67.00 109.00 277.00 422.00 699.00 415.00
End of Period
32.00 21.00 17.00 39.00 45.00 48.00 44.00 83.00 67.00 109.00 277.00 422.00 699.00 415.00 510.00
Change
-22.00 -11.00 -3.00 21.00 6.00 3.00 -4.00 39.00 -16.00 42.00 167.00 145.00 276.00 -284.00 95.00
Non-Cash Balances
Depreciation and Amortization
4.00 5.00 6.00 8.00 9.00 8.00 11.00 11.00 20.00 31.00 48.00 56.00 67.00 81.00 99.00
Stock Based Compensation
- - - - - - 1.00 1.00 1.00 3.00 3.00 2.00 4.00 3.00 5.00 7.00 9.00 9.00
Other
2.00 -3.00 -1.00 4.00 26.00 12.00 -13.00 7.00 4.00 -9.00 14.00 6.00 -171.00 160.00 232.00
Highlighted metrics
Free Cash Flow (FCF)
-24.00 -1.00 2.00 1.00 1.00 -9.00 4.00 57.00 -6.00 128.00 10.00 -54.00 3.00 21.00 -182.00
Cash Conversion Cycle (CCC)
- - 33.00 19.00 39.00 48.00 68.00 26.00 39.00 39.00 37.00 77.00 71.00 67.00 82.00 33.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows